ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: BCR-ABL could directly interact and phosphorylate beta-catenin at Y86 and Y654 residues and the inhibition of beta-catenin with RNAi suppressed the growth of CML cells in synergism with IM [28].